Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Improving drug-like properties of insulin and GLP-1 via molecule design and formulation and improving diabetes management with device & drug delivery
Sergei Pechenov, Himanshu Bhattacharjee, Dan Yin, et al.
Advanced Drug Delivery Reviews (2017) Vol. 112, pp. 106-122
Closed Access | Times Cited: 20

Showing 20 citing articles:

Semi-solid extrusion 3D printing in drug delivery and biomedicine: Personalised solutions for healthcare challenges
Iria Seoane‐Viaño, Patricija Januskaite, Carmen Alvarez‐Lorenzo, et al.
Journal of Controlled Release (2021) Vol. 332, pp. 367-389
Open Access | Times Cited: 248
Ionic liquid-mediated delivery of insulin to buccal mucosa
Amogh Vaidya, Samir Mitragotri
Journal of Controlled Release (2020) Vol. 327, pp. 26-34
Closed Access | Times Cited: 91
Baicalein and baicalin as Zika virus inhibitors
Adrian Oo, Boon‐Teong Teoh, Sing‐Sin Sam, et al.
Archives of Virology (2018) Vol. 164, Iss. 2, pp. 585-593
Closed Access | Times Cited: 82
Development of an orally delivered GLP-1 receptor agonist through peptide engineering and drug delivery to treat chronic disease
Sergei Pechenov, Jefferson D. Revell, Sarah Will, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 50
Stabilized helical peptides: overview of the technologies and its impact on drug discovery
Mark Klein
Expert Opinion on Drug Discovery (2017) Vol. 12, Iss. 11, pp. 1117-1125
Closed Access | Times Cited: 59
Hydrogel microcapsules containing engineered bacteria for sustained production and release of protein drugs
Yu Chang, Xinyu Zhang, Gaoju Pang, et al.
Biomaterials (2022) Vol. 287, pp. 121619-121619
Closed Access | Times Cited: 25
PDCdb: the biological activity and pharmaceutical information of peptide–drug conjugate (PDC)
Xiuna Sun, Hanyang Li, Zhen Chen, et al.
Nucleic Acids Research (2024) Vol. 53, Iss. D1, pp. D1476-D1485
Open Access | Times Cited: 4
Strategies for improving diabetic therapy via alternative administration routes that involve stimuli-responsive insulin-delivering systems
Yu‐Jung Lin, Fwu‐Long Mi, Po‐Yen Lin, et al.
Advanced Drug Delivery Reviews (2018) Vol. 139, pp. 71-82
Closed Access | Times Cited: 36
Sustained Release of Exendin 4 Using Injectable and Ionic-Nano-Complex Forming Polymer Hydrogel System for Long-Term Treatment of Type 2 Diabetes Mellitus
Bo‐Bae Seo, Mi‐Ran Park, Soo-Chang Song
ACS Applied Materials & Interfaces (2019) Vol. 11, Iss. 17, pp. 15201-15211
Closed Access | Times Cited: 32
Revisiting amino acids and peptides as anti-glycation agents
Harsha Chilukuri, Mahesh J. Kulkarni, Moneesha Fernandes
MedChemComm (2018) Vol. 9, Iss. 4, pp. 614-624
Open Access | Times Cited: 26
Implantable small device enabled with magnetic actuation for on-demand and pulsatile drug delivery
Seung Ho Lee, Byung Hwi Kim, Chun Gwon Park, et al.
Journal of Controlled Release (2018) Vol. 286, pp. 224-230
Closed Access | Times Cited: 25
The industrial design, translation, and development strategies for long-acting peptide delivery
Bin Yang, Ana Gomes dos Santos, Sanyogitta Puri, et al.
Expert Opinion on Drug Delivery (2022) Vol. 19, Iss. 10, pp. 1233-1245
Closed Access | Times Cited: 14
Fighting type 2 diabetes: Formulation strategies for peptide-based therapeutics
Carlos Bendicho-Lavilla, Iria Seoane‐Viaño, Francisco J. Otero‐Espinar, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 12, Iss. 2, pp. 621-636
Open Access | Times Cited: 18
Injectable systems for long-lasting insulin therapy
Kumar Kulldeep Niloy, Tao L. Lowe
Advanced Drug Delivery Reviews (2023) Vol. 203, pp. 115121-115121
Open Access | Times Cited: 6
Oncolytic bacteria VNP20009 expressing IFNβ inhibits melanoma progression by remodeling the tumor microenvironment
Lina Liu, Qiang Li, Chen Chen, et al.
iScience (2024) Vol. 27, Iss. 4, pp. 109372-109372
Open Access | Times Cited: 2
A temperature-responsive dual-hormone foam nanoengine improves rectal absorptivity of insulin-pramlintide for diabetes treatment
Shujun Feng, Yu Zhang, Chunyuan Hou, et al.
Science Advances (2024) Vol. 10, Iss. 35
Open Access | Times Cited: 1
Pharmacoeconomic analysis (CER) of Dulaglutide and Liraglutide in the treatment of patients with type 2 diabetes
Yu Su, Shuo Zhang, Zezhen Wu, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 3
Novel GLP-1(28–36) amide-derived hybrid peptide A3 with weight loss and hypoglycemic activities
Wang Chen, Binbin Gong, Zhu Qianqian, et al.
European Journal of Pharmacology (2023) Vol. 961, pp. 176200-176200
Closed Access | Times Cited: 1
Chemical chaperone-conjugated exendin-4 as a cytoprotective agent for pancreatic β-cells
Sohee Son, Eun Ji Park, Yejin Kim, et al.
The International Journal of Biochemistry & Cell Biology (2018) Vol. 105, pp. 13-19
Closed Access | Times Cited: 2
Injectable Systems for Long-Lasting Insulin Therapy
Kumar Kulldeep Niloy
(2019)
Open Access | Times Cited: 1
Page 1

Scroll to top